Literature DB >> 9285733

Childhood moyamoya disease: hemodynamic MRI.

A A Tzika1, R L Robertson, P D Barnes, S Vajapeyam, P E Burrows, S T Treves, R M Scott.   

Abstract

BACKGROUND: Childhood moyamoya disease is a rare progressive cerebrovascular disease.
OBJECTIVE: To evaluate cerebral hemodynamics using dynamic Gd-DTPA-enhanced imaging in children with moyamoya disease.
MATERIALS AND METHODS: Eight children (2-11 years of age) with the clinical and angiographic findings typical of moyamoya disease, before and/or after surgical intervention (pial synangiosis), underwent conventional MR imaging (MRI) and hemodynamic MR imaging (HMRI). HMRI used a spoiled gradient-echo with low flip angle (10 deg) and long TE (TR/TE = 24/15 ms) to minimize T 1 effects and emphasize T 2* weighting. Raw and calculated hemodynamic images were reviewed. Three-dimensional time-of-flight MR angiography (MRA) and perfusion brain single photon emission computed tomography (SPECT) were also performed.
RESULTS: Abnormal hemodynamic maps resulting from vascular stenosis or occlusion and basal collaterals were observed in six patient studies. HMRI depicted perfusion dynamics of affected cerebrovascular territories, detected cortical perfusion deficits, and complemented conventional MRI and MRA. HMRI findings were consistent with those of catheter angiography and perfusion SPECT.
CONCLUSION: Our preliminary experience suggests that HMRI may be of value in the preoperative and postoperative evaluation of surgical interventions in moyamoya disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285733     DOI: 10.1007/s002470050212

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  4 in total

Review 1.  Perfusion-weighted magnetic resonance imaging of the brain: techniques and application in children.

Authors:  Thierry A G M Huisman; A Gregory Sorensen
Journal:  Eur Radiol       Date:  2003-06-25       Impact factor: 5.315

2.  Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.

Authors:  Robert Goetti; Ruth O'Gorman; Nadia Khan; Christian J Kellenberger; Ianina Scheer
Journal:  Neuroradiology       Date:  2013-02-13       Impact factor: 2.804

3.  Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience.

Authors:  Seung-Koo Lee; Dong Ik Kim; Eun-Kee Jeong; Si-Yeon Kim; Sang Heum Kim; Yon Kwon In; Dong-Seok Kim; Joong-Uhn Choi
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

4.  Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.

Authors:  Alessandra D'Amico; Lorenzo Ugga; Sirio Cocozza; Sara Maria Delle Acque Giorgio; Domenico Cicala; Claudia Santoro; Daniela Melis; Giuseppe Cinalli; Arturo Brunetti; Sabina Pappatà
Journal:  Neurol Sci       Date:  2020-07-10       Impact factor: 3.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.